Algeria vs France: New cases tested for RR-/MDR-TB
Algeria
1.0%
in 2023
France
1.8%
in 2024
Algeria rank
183rd
France rank
182nd
New cases tested for RR-/MDR-TB over time
- Algeria
- France
How they compare
France currently reports 1.8% against 1.0% in Algeria, a difference of 0.8%.
That makes France's figure about 1.8 times Algeria's.
The two have swapped places 2 times across 10 shared years of data; in 2005 it was France ahead.
Algeria ranks 183rd and France ranks 182nd of 192 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.1% | 47.0% | 37.9% | France |
| 2010s | 3.7% | 83.6% | 79.9% | France |
| 2020s | 1.2% | 2.1% | 0.9% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Algeria or France?
- France, at 1.8% against 1.0% in Algeria as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Algeria and France?
- 0.8%, with France ahead.
- How many years of comparable data are there for Algeria and France?
- 10 years are reported by both, from 2005 to 2023.
- How do Algeria and France rank globally for new cases tested for rr-/mdr-tb?
- Algeria ranks 183rd and France ranks 182nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.